The clinical study that evaluated OrthoCor Medical's 27.12-MHz pulsed electromagnetic field (PEMF) device, was conducted between October 2024 and January 2025. It was a prospective, multi-center, randomized clinical trial focused on managing soft tissue and joint pain.
(1)
(0)
BioElectronics Corporation (BIEL) Stock Research Links